Literature DB >> 9083013

Brain contains HNK-1 immunoreactive O-glycans of the sulfoglucuronyl lactosamine series that terminate in 2-linked or 2,6-linked hexose (mannose).

C T Yuen1, W Chai, R W Loveless, A M Lawson, R U Margolis, T Feizi.   

Abstract

The monoclonal antibody HNK-1 originally raised to an antigenic marker of natural killer cells also binds to selected regions in nervous tissue. The antigen is a carbohydrate that has attracted much interest as its expression is developmentally regulated in nervous tissue, and it is found, and proposed to be a ligand, on several of the adhesive glycoproteins of the nervous system. It is also expressed on glycolipids and proteoglycans, and is the target of monoclonal auto-antibodies that give rise to a demyelinating disease. The epitope, as characterized on glycolipids isolated from the nervous system, is expressed on 3-sulfated glucuronic acid joined by beta1-3-linkage to a neolacto backbone. Here we exploit the neoglycolipid technology, in conjunction with immunodetection and in situ liquid secondary ion mass spectrometry, to characterize HNK-1-positive oligosaccharide chains derived by reductive alkaline release from total brain glycopeptides. The immunoreactive oligosaccharides detected are tetra- to octasaccharides that are very minor components among a heterogeneous population, each representing less than 0.1% of the starting material. Their peripheral and backbone sequences resemble those of the HNK-1-positive glycolipids. An unexpected finding is that they terminate not with N-acetylgalactosaminitol but with hexitol (2-substituted and 2,6-disubstituted). In a tetrasaccharide investigated in the greatest detail, the hexitol is identified as 2-substituted mannitol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083013     DOI: 10.1074/jbc.272.14.8924

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Regulated expression and neural functions of human natural killer-1 (HNK-1) carbohydrate.

Authors:  Yasuhiko Kizuka; Shogo Oka
Journal:  Cell Mol Life Sci       Date:  2012-06-06       Impact factor: 9.261

2.  O-mannosylation precedes and potentially controls the N-glycosylation of a yeast cell wall glycoprotein.

Authors:  Margit Ecker; Vladimir Mrsa; Ilja Hagen; Rainer Deutzmann; Sabine Strahl; Widmar Tanner
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

3.  RPTPζ/phosphacan is abnormally glycosylated in a model of muscle-eye-brain disease lacking functional POMGnT1.

Authors:  C A Dwyer; E Baker; H Hu; R T Matthews
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

4.  Induction of Antibodies Directed Against Branched Core O-Mannosyl Glycopeptides-Selectivity Complimentary to the ConA Lectin.

Authors:  Sabine Stahl; Jin Yu; Oliver C Grant; Christian Pett; S Strahl; Robert J Woods; Ulrika Westerlind
Journal:  Chemistry       Date:  2017-02-16       Impact factor: 5.236

Review 5.  Mammalian O-mannosylation: unsolved questions of structure/function.

Authors:  Stephanie H Stalnaker; Ryan Stuart; Lance Wells
Journal:  Curr Opin Struct Biol       Date:  2011-09-22       Impact factor: 6.809

6.  Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie)

Authors:  S Kim; V Westphal; G Srikrishna; D P Mehta; S Peterson; J Filiano; P S Karnes; M C Patterson; H H Freeze
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

Review 7.  Golgi glycosylation and human inherited diseases.

Authors:  Hudson H Freeze; Bobby G Ng
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-09-01       Impact factor: 10.005

8.  Syntheses of alpha-dystroglycan derived glycosyl amino acids carrying a novel mannosyl serine/threonine linkage.

Authors:  J Seifert; T Ogawa; S Kurono; Y Ito
Journal:  Glycoconj J       Date:  2000-06       Impact factor: 2.916

9.  Developmental changes in the biochemical and immunological characters of the carbohydrate moiety of neuroglycan C, a brain-specific chondroitin sulfate proteoglycan.

Authors:  Takuya Shuo; Sachiko Aono; Fumiko Matsui; Yoshihito Tokita; Hiroshi Maeda; Katsuhiko Shimada; Atsuhiko Oohira
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

10.  Comparison of the substrate specificities and catalytic properties of the sister N-acetylglucosaminyltransferases, GnT-V and GnT-Vb (IX).

Authors:  Gerardo Alvarez-Manilla; Karolyn Troupe; Maria Fleming; Erika Martinez-Uribe; Michael Pierce
Journal:  Glycobiology       Date:  2009-10-21       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.